Circulating resistin levels have an emerging role as biomarkers for a variety of diseases, including glucose metabolism and obesity [30, 31], diabetes [32], cancer [33], inflammatory diseases such as inflammatory bowel disease [34], and cardiovascular diseases [9, 10]. This evidence concerns the gene RETN and inflammatory bowel disease.